Acrivon Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRV and other ETFs, options, and stocks.About ACRV
Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3).
CEOPeter Blume-Jensen
CEOPeter Blume-Jensen
Employees78
Employees78
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2018
Founded2018
Employees78
Employees78
ACRV Key Statistics
Market cap43.90M
Market cap43.90M
Price-Earnings ratio-0.58
Price-Earnings ratio-0.58
Dividend yield—
Dividend yield—
Average volume2.12M
Average volume2.12M
High today$1.42
High today$1.42
Low today$1.32
Low today$1.32
Open price$1.39
Open price$1.39
Volume654.70K
Volume654.70K
52 Week high$10.29
52 Week high$10.29
52 Week low$1.30
52 Week low$1.30
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ACRV. This list is generated using Robinhood data, and it’s not a recommendation.